Cef 3 200 Cap
Cef 3 200 CapIndication:Upper and lower respiratory tract infections, Urinary tract infections, Gonococcal urethritis, Acute otitis media.Dosage & Administration:Capsule:200 mg - 400 mg, as a single dose or in 2 divided doses daily for 7-14 days, according to the severity of infection.Powder for Suspension:Child dose: 8 mg/kg daily as a single dose or in two divided doses for 7-14 days according to the severity of infection or for children of age 1/2-1 year: 75 mg; 1-4 years: 100 mg; 5-10 years: 200 mg; 11-12 years: 300 mg; above 12 years: adult dose...
Tk.35.10/=
Cef 3 DS cap 400 mg
Cef 3 DS capIndication:Upper and lower respiratory tract infections, Urinary tract infections, Gonococcal urethritis, Acute otitis media.Dosage & Administration:Capsule:200 mg - 400 mg, as a single dose or in 2 divided doses daily for 7-14 days, according to the severity of infection.Powder for Suspension:Child dose: 8 mg/kg daily as a single dose or in two divided doses for 7-14 days according to the severity of infection or for children of age 1/2-1 year: 75 mg; 1-4 years: 100 mg; 5-10 years: 200 mg; 11-12 years: 300 mg; above 12 years: adult dose...
Tk.60.00/=
Cef-3 Paediatric Drops 21ml
Cef-3 Paediatric Drops 21mlIndication:Upper and lower respiratory tract infections, Urinary tract infections, Gonococcal urethritis, Acute otitis media.Dosage & Administration:Capsule:200 mg - 400 mg, as a single dose or in 2 divided doses daily for 7-14 days, according to the severity of infection.Powder for Suspension:Child dose: 8 mg/kg daily as a single dose or in two divided doses for 7-14 days according to the severity of infection or for children of age 1/2-1 year: 75 mg; 1-4 years: 100 mg; 5-10 years: 200 mg; 11-12 years: 300 mg; above 12 years: adult dose...
Tk.100.30/=
Cef-3 PFS 30ml
Cef-3 PFS 30mlIndication:Upper and lower respiratory tract infections, Urinary tract infections, Gonococcal urethritis, Acute otitis media.Dosage & Administration:Capsule:200 mg - 400 mg, as a single dose or in 2 divided doses daily for 7-14 days, according to the severity of infection.Powder for Suspension:Child dose: 8 mg/kg daily as a single dose or in two divided doses for 7-14 days according to the severity of infection or for children of age 1/2-1 year: 75 mg; 1-4 years: 100 mg; 5-10 years: 200 mg; 11-12 years: 300 mg; above 12 years: adult dose...
Tk.135.40/=
Cef-3 PFS 50ml
Cef-3 PFS 50mlIndication:Upper and lower respiratory tract infections, Urinary tract infections, Gonococcal urethritis, Acute otitis media.Dosage & Administration:Capsule:200 mg - 400 mg, as a single dose or in 2 divided doses daily for 7-14 days, according to the severity of infection.Powder for Suspension:Child dose: 8 mg/kg daily as a single dose or in two divided doses for 7-14 days according to the severity of infection or for children of age 1/2-1 year: 75 mg; 1-4 years: 100 mg; 5-10 years: 200 mg; 11-12 years: 300 mg; above 12 years: adult dose...
Tk.210.63/=
Cef-3 PFS 75 ML
Cef-3 PFS 75 MLIndication:Upper and lower respiratory tract infections, Urinary tract infections, Gonococcal urethritis, Acute otitis media.Dosage & Administration:Capsule:200 mg - 400 mg, as a single dose or in 2 divided doses daily for 7-14 days, according to the severity of infection.Powder for Suspension:Child dose: 8 mg/kg daily as a single dose or in two divided doses for 7-14 days according to the severity of infection or for children of age 1/2-1 year: 75 mg; 1-4 years: 100 mg; 5-10 years: 200 mg; 11-12 years: 300 mg; above 12 years: adult dose...
Tk.250.00/=
Emixef 200 mg Cap
Emixef 200 mg CapDescriptionCefixime is a semi-synthetic, broad spectrum cephalosporin antibiotic of third generation for oral administration. It is a bactericidal antibiotic, kills bacteria by interfering in the synthesis of the bacterial cell wall. Cefixime is highly stable in the presence of beta-lactamase enzymes. Cefixime has marked in -vitro bactericidal activity against a wide variety of Gram-positive and Gram-negative organisms including beta lactamase producers.Clinical efficacy of Cefixime has been demonstrated in infections caused by commonly occurring pathogens including Gram-positive organism Streptococcus pneumoniae, Streptococcus pyogenes, Gram-negative organism Escherichia coli, Proteus mirabilis, Klebsiella spp., Haemophilus influenzae (beta-lactamase positive and negative), Moraxella catarrhalis (beta-lactamase positive and negative), Salmonella typhi and Enterobacter species.IndicationsEmixef is indicated in the following infectious diseases -Respiratory Tract Infections:PneumoniaSinusitisPharyngitis and TonsillitisAcute Bronchitis and Acute Exacerbations of ChronicBronchitis (AECB)Otitis MediaTyphoid FeverUrinary Tract InfectionsUncomplicated gonorrhea (cervical/urethral)Dosage & AdministrationThe usual treatment of Emixef is 7 days. This may be continued for up to 14 days according to the severity of infection.Emixef CapsuleAdult and child over 12 years: 200 or 400 mg daily as a single dose or in two divided doses.Emixef SuspensionChild over 6 months: 8 mg/kg daily as a single dose or in 2 divided dosesSide EffectsCefixime is generally well tolerated. The majority of adverse reactions observed in clinical trials are mild and self limiting in nature.Gastro-intestinal disturbance: Diarrhea (if severe diarrhea occurs, Cefixime should be discontinued), changes in the color of stool, nausea, abdominal pain, dyspepsia, vomiting, flatulence have been reported. CNS disturbances: Headache, dizziness.Others: Hypersensitivity reactions which usually subsided upon discontinuation of therapy; infrequent and reversible hematological changes; elevation of serum amylase.PrecautionsCefixime should be prescribed with caution in individuals with a history of gastrointestinal diseases, particularly colitis. Dosage adjustment is only necessary in severe renal failure (creatinine clearance < 20 ml/min)Use in Pregnancy & LactationPregnancy: Pregnancy category B. There are no adequate and well-controlled studies in pregnant women. Because animal reproduction studies are not always predictive of human response, this drug should be used during pregnancy only if clearly needed.Lactation: It is not known whether Cefixime is excreted in human milk. Consideration should be given to discontinuing nursing temporarily during treatment with this drug.Use in ElderlyNo special precautions are necessary. No dosage adjustment is required for elderlyDrug InteractionCarbamazepine: Elevated carbamazepine levels have been reported in postmarketing experience when Cefixime is administered concomitantly. Drug monitoring may be of assistance in detecting alterations in carbamazepine plasma concentrations.Warfarin and Anticoagulants: Increased prothrombin time, with or without clinical bleeding, has been reported when cefixime is administered concomitantly.Over DoseGastric lavage may be indicated; otherwise, no specific antidote exists. Cefixime is not removed in significant quantities from the circulation by hemodialysis or peritoneal dialysis. Adverse reactions in small numbers of healthy adult volunteers receiving single doses up to 2 g of Cefixime did not differ from the profile seen in patients treated at the recommended doses...
Tk.35.00/=
Emixef 400 mg Cap
Emixef 400 mg CapDescriptionCefixime is a semi-synthetic, broad spectrum cephalosporin antibiotic of third generation for oral administration. It is a bactericidal antibiotic, kills bacteria by interfering in the synthesis of the bacterial cell wall. Cefixime is highly stable in the presence of beta-lactamase enzymes. Cefixime has marked in -vitro bactericidal activity against a wide variety of Gram-positive and Gram-negative organisms including beta lactamase producers.Clinical efficacy of Cefixime has been demonstrated in infections caused by commonly occurring pathogens including Gram-positive organism Streptococcus pneumoniae, Streptococcus pyogenes, Gram-negative organism Escherichia coli, Proteus mirabilis, Klebsiella spp., Haemophilus influenzae (beta-lactamase positive and negative), Moraxella catarrhalis (beta-lactamase positive and negative), Salmonella typhi and Enterobacter species.IndicationsEmixef is indicated in the following infectious diseases -Respiratory Tract Infections:PneumoniaSinusitisPharyngitis and TonsillitisAcute Bronchitis and Acute Exacerbations of ChronicBronchitis (AECB)Otitis MediaTyphoid FeverUrinary Tract InfectionsUncomplicated gonorrhea (cervical/urethral)Dosage & AdministrationThe usual treatment of Emixef is 7 days. This may be continued for up to 14 days according to the severity of infection.Emixef CapsuleAdult and child over 12 years: 200 or 400 mg daily as a single dose or in two divided doses.Emixef SuspensionChild over 6 months: 8 mg/kg daily as a single dose or in 2 divided dosesSide EffectsCefixime is generally well tolerated. The majority of adverse reactions observed in clinical trials are mild and self limiting in nature.Gastro-intestinal disturbance: Diarrhea (if severe diarrhea occurs, Cefixime should be discontinued), changes in the color of stool, nausea, abdominal pain, dyspepsia, vomiting, flatulence have been reported. CNS disturbances: Headache, dizziness.Others: Hypersensitivity reactions which usually subsided upon discontinuation of therapy; infrequent and reversible hematological changes; elevation of serum amylase.PrecautionsCefixime should be prescribed with caution in individuals with a history of gastrointestinal diseases, particularly colitis. Dosage adjustment is only necessary in severe renal failure (creatinine clearance < 20 ml/min)Use in Pregnancy & LactationPregnancy: Pregnancy category B. There are no adequate and well-controlled studies in pregnant women. Because animal reproduction studies are not always predictive of human response, this drug should be used during pregnancy only if clearly needed.Lactation: It is not known whether Cefixime is excreted in human milk. Consideration should be given to discontinuing nursing temporarily during treatment with this drug.Use in ElderlyNo special precautions are necessary. No dosage adjustment is required for elderlyDrug InteractionCarbamazepine: Elevated carbamazepine levels have been reported in postmarketing experience when Cefixime is administered concomitantly. Drug monitoring may be of assistance in detecting alterations in carbamazepine plasma concentrations.Warfarin and Anticoagulants: Increased prothrombin time, with or without clinical bleeding, has been reported when cefixime is administered concomitantly.Over DoseGastric lavage may be indicated; otherwise, no specific antidote exists. Cefixime is not removed in significant quantities from the circulation by hemodialysis or peritoneal dialysis. Adverse reactions in small numbers of healthy adult volunteers receiving single doses up to 2 g of Cefixime did not differ from the profile seen in patients treated at the recommended doses...
Tk.50.00/=
Emixef DS Susp. 50 ml
Emixef DS Susp. 50 mlDescriptionCefixime is a semi-synthetic, broad spectrum cephalosporin antibiotic of third generation for oral administration. It is a bactericidal antibiotic, kills bacteria by interfering in the synthesis of the bacterial cell wall. Cefixime is highly stable in the presence of beta-lactamase enzymes. Cefixime has marked in -vitro bactericidal activity against a wide variety of Gram-positive and Gram-negative organisms including beta lactamase producers.Clinical efficacy of Cefixime has been demonstrated in infections caused by commonly occurring pathogens including Gram-positive organism Streptococcus pneumoniae, Streptococcus pyogenes, Gram-negative organism Escherichia coli, Proteus mirabilis, Klebsiella spp., Haemophilus influenzae (beta-lactamase positive and negative), Moraxella catarrhalis (beta-lactamase positive and negative), Salmonella typhi and Enterobacter species.IndicationsEmixef is indicated in the following infectious diseases -Respiratory Tract Infections:PneumoniaSinusitisPharyngitis and TonsillitisAcute Bronchitis and Acute Exacerbations of ChronicBronchitis (AECB)Otitis MediaTyphoid FeverUrinary Tract InfectionsUncomplicated gonorrhea (cervical/urethral)Dosage & AdministrationThe usual treatment of Emixef is 7 days. This may be continued for up to 14 days according to the severity of infection.Emixef CapsuleAdult and child over 12 years: 200 or 400 mg daily as a single dose or in two divided doses.Emixef SuspensionChild over 6 months: 8 mg/kg daily as a single dose or in 2 divided dosesSide EffectsCefixime is generally well tolerated. The majority of adverse reactions observed in clinical trials are mild and self limiting in nature.Gastro-intestinal disturbance: Diarrhea (if severe diarrhea occurs, Cefixime should be discontinued), changes in the color of stool, nausea, abdominal pain, dyspepsia, vomiting, flatulence have been reported. CNS disturbances: Headache, dizziness.Others: Hypersensitivity reactions which usually subsided upon discontinuation of therapy; infrequent and reversible hematological changes; elevation of serum amylase.PrecautionsCefixime should be prescribed with caution in individuals with a history of gastrointestinal diseases, particularly colitis. Dosage adjustment is only necessary in severe renal failure (creatinine clearance < 20 ml/min)Use in Pregnancy & LactationPregnancy: Pregnancy category B. There are no adequate and well-controlled studies in pregnant women. Because animal reproduction studies are not always predictive of human response, this drug should be used during pregnancy only if clearly needed.Lactation: It is not known whether Cefixime is excreted in human milk. Consideration should be given to discontinuing nursing temporarily during treatment with this drug.Use in ElderlyNo special precautions are necessary. No dosage adjustment is required for elderlyDrug InteractionCarbamazepine: Elevated carbamazepine levels have been reported in postmarketing experience when Cefixime is administered concomitantly. Drug monitoring may be of assistance in detecting alterations in carbamazepine plasma concentrations.Warfarin and Anticoagulants: Increased prothrombin time, with or without clinical bleeding, has been reported when cefixime is administered concomitantly.Over DoseGastric lavage may be indicated; otherwise, no specific antidote exists. Cefixime is not removed in significant quantities from the circulation by hemodialysis or peritoneal dialysis. Adverse reactions in small numbers of healthy adult volunteers receiving single doses up to 2 g of Cefixime did not differ from the profile seen in patients treated at the recommended doses...
Tk.280.00/=
Fix-A 200mg Capsule
Fix-A 200mg CapsuleDESCRIPTIONFIX-A (Cefixime) is a third generation semisynthetic cephalosporin antibiotic for oral administration. FIX-A (Cefixime) is bactericidal against a broad spectrum of gram positive and gram-negative bacteria at easily achievable plasma concentrations. FIX-A (Cefixime) is also highly stable in the presence of beta-lactamase enzyme. As a result, many organism resistant to penicillins and some cephalosporins due to the presence of beta-lactamases, may be susceptible to FIX-A (Cefixime). FIX-A (Cefixime) exhibits very good activity against most of the Enterobacteriaceae, Haemophilus influenzae and Neisseria gonorrhoeae (including -lactamase producing strains), -hemolytic streptococci of groups A and B and Streptococcus pneumoniae.Absorption is about 40% to 50% whether administered with or without food.COMPOSITIONCapsule: Each capsule contains Cefixime Trihydrate USP equivalent to Cefixime 200 mg.DS Capsule : Each capsule contains Cefixime Trihydrate USP equivalent to Cefixime 400 mg.Powder for suspension : Each 5 ml suspension contains CefiximeTrihydrate USP equivalent to Cefixime 100 mg after reconstitution.INDICATIONSFIX-A (Cefixime) is indicated for the treatment of the following acute infections caused by the susceptible microorganisms. 1) Upper respiratory tract infections e.g. otitis media and other URTI where the causative organism is known or suspected to be resistant to other commonly used antibiotics, or where treatment failure may carry significant risk. 2) Lower respiratory tract infections e.g. bronchitis. 3)Urinary tract infections e.g. cystitis, cystourethritis, uncomplicated pyelonephritis.4) Uncomplicated gonorrhea (cervical/ urethral).DOSAGE AND ADMINISTRATIONAdult and children over 12 years : The recommended adult dose is 200-400 mg (1 to 2 Capsules) daily, given either as a single dose or in two divided doses for 7-14 days depending on the severity of the infection.For the treatment of uncomplicated cervical/urethral gonococcal infections, a single oral dose of Cefixime 400 mg (Fix-A DS) is recommended. Single 800 mg may be given if essential.Children upto 12 years : Usually 8mg/kg/day given as a single dose or in two divided doses or for children of age :1/2 - 1 Year : 3.75 ml or 75 mg1 - 4 Years : 5 ml or 100 mg5 - 10 Years : 10 ml or 200 mg11-12 Years : 15 ml or 300 mg above 12 Years : adult dose should be given.OR AS DIRECTED BY THE PHYSICIAN.SIDE EFFECTSThe drug is generally well tolerated. The most frequent side effects observed are diarrhea and stool changes; that has been more commonly associated with higher doses. The drug should be discontinued if marked diarrhea occur. Other side effects seen less frequently are nausea, abdominal pain, dyspepsia, vomiting, flatulence, headache and dizziness. Allergies in the form of rash, pruritus, urticaria, drug fever and arthralgia have been reported. These reactions usually subsided upon discontinuation of therapy.PRECAUTIONSThe drug should be prescribed with caution in individuals with a history of gastrointestinal disease, particularly colitis. The drug should be given with caution in patients with marked impaired renal function as well as those undergoing continuous ambulatory peritoneal dialysis and hemodialysis. Dosage adjustment is only necessary in severe renal failure (creatinine clearance <20 ml. min-1 ), in that case a dose of 200 mg once daily should not be exceeded.Use in pregnancy and lactationThere are no adequate and well controlled studies in pregnant women. FIX-A (Cefixime) should therefore not be used in pregnancy or in nursing mothers unless considered essential by the physician.CONTRAINDICATIONSHypersensitivity to cephalosporin antibiotics.SUPPLYFIX-A Capsule : Each box contains 34 capsules in Alu-Alu blister strips.FIX-A DS Capsule : Each box contains 24 capsules in Alu-Alu blister strips.FIX-A powder for suspension 37.5 ml: Each bottle contains dry powder for the preparation of 37.5 ml suspension. A 5 ml spoon and a 10 ml measuring cup is given.FIX-A powder for suspension 50 ml: Each bottle contains dry powderfor the preparation of 50 ml suspension. A 5 ml spoon and a 10 ml measuring cup is given.FIX-A powder for suspension 75 ml: Each bottle contains dry powder for the preparation of 75 ml suspension. A 5 ml spoon and a 10 ml measuring cup is given...
Tk.35.00/=
Fix-A 21ml Paediatric Drops
Fix-A 21ml Paediatric DropsDESCRIPTIONFIX-A (Cefixime) is a third generation semisynthetic cephalosporin antibiotic for oral administration. FIX-A (Cefixime) is bactericidal against a broad spectrum of gram positive and gram-negative bacteria at easily achievable plasma concentrations. FIX-A (Cefixime) is also highly stable in the presence of beta-lactamase enzyme. As a result, many organism resistant to penicillins and some cephalosporins due to the presence of beta-lactamases, may be susceptible to FIX-A (Cefixime). FIX-A (Cefixime) exhibits very good activity against most of the Enterobacteriaceae, Haemophilus influenzae and Neisseria gonorrhoeae (including -lactamase producing strains), -hemolytic streptococci of groups A and B and Streptococcus pneumoniae.Absorption is about 40% to 50% whether administered with or without food.COMPOSITIONCapsule: Each capsule contains Cefixime Trihydrate USP equivalent to Cefixime 200 mg.DS Capsule : Each capsule contains Cefixime Trihydrate USP equivalent to Cefixime 400 mg.Powder for suspension : Each 5 ml suspension contains CefiximeTrihydrate USP equivalent to Cefixime 100 mg after reconstitution.INDICATIONSFIX-A (Cefixime) is indicated for the treatment of the following acute infections caused by the susceptible microorganisms. 1) Upper respiratory tract infections e.g. otitis media and other URTI where the causative organism is known or suspected to be resistant to other commonly used antibiotics, or where treatment failure may carry significant risk. 2) Lower respiratory tract infections e.g. bronchitis. 3)Urinary tract infections e.g. cystitis, cystourethritis, uncomplicated pyelonephritis.4) Uncomplicated gonorrhea (cervical/ urethral).DOSAGE AND ADMINISTRATIONAdult and children over 12 years : The recommended adult dose is 200-400 mg (1 to 2 Capsules) daily, given either as a single dose or in two divided doses for 7-14 days depending on the severity of the infection.For the treatment of uncomplicated cervical/urethral gonococcal infections, a single oral dose of Cefixime 400 mg (Fix-A DS) is recommended. Single 800 mg may be given if essential.Children upto 12 years : Usually 8mg/kg/day given as a single dose or in two divided doses or for children of age :1/2 - 1 Year : 3.75 ml or 75 mg1 - 4 Years : 5 ml or 100 mg5 - 10 Years : 10 ml or 200 mg11-12 Years : 15 ml or 300 mg above 12 Years : adult dose should be given.OR AS DIRECTED BY THE PHYSICIAN.SIDE EFFECTSThe drug is generally well tolerated. The most frequent side effects observed are diarrhea and stool changes; that has been more commonly associated with higher doses. The drug should be discontinued if marked diarrhea occur. Other side effects seen less frequently are nausea, abdominal pain, dyspepsia, vomiting, flatulence, headache and dizziness. Allergies in the form of rash, pruritus, urticaria, drug fever and arthralgia have been reported. These reactions usually subsided upon discontinuation of therapy.PRECAUTIONSThe drug should be prescribed with caution in individuals with a history of gastrointestinal disease, particularly colitis. The drug should be given with caution in patients with marked impaired renal function as well as those undergoing continuous ambulatory peritoneal dialysis and hemodialysis. Dosage adjustment is only necessary in severe renal failure (creatinine clearance <20 ml. min-1 ), in that case a dose of 200 mg once daily should not be exceeded.Use in pregnancy and lactationThere are no adequate and well controlled studies in pregnant women. FIX-A (Cefixime) should therefore not be used in pregnancy or in nursing mothers unless considered essential by the physician.CONTRAINDICATIONSHypersensitivity to cephalosporin antibiotics.SUPPLYFIX-A Capsule : Each box contains 34 capsules in Alu-Alu blister strips.FIX-A DS Capsule : Each box contains 24 capsules in Alu-Alu blister strips.FIX-A powder for suspension 37.5 ml: Each bottle contains dry powder for the preparation of 37.5 ml suspension. A 5 ml spoon and a 10 ml measuring cup is given.FIX-A powder for suspension 50 ml: Each bottle contains dry powderfor the preparation of 50 ml suspension. A 5 ml spoon and a 10 ml measuring cup is given.FIX-A powder for suspension 75 ml: Each bottle contains dry powder for the preparation of 75 ml suspension. A 5 ml spoon and a 10 ml measuring cup is given...
Tk.100.30/=
Fix-A 37.5ml suspension
Fix-A 37.5ml suspensionDESCRIPTIONFIX-A (Cefixime) is a third generation semisynthetic cephalosporin antibiotic for oral administration. FIX-A (Cefixime) is bactericidal against a broad spectrum of gram positive and gram-negative bacteria at easily achievable plasma concentrations. FIX-A (Cefixime) is also highly stable in the presence of beta-lactamase enzyme. As a result, many organism resistant to penicillins and some cephalosporins due to the presence of beta-lactamases, may be susceptible to FIX-A (Cefixime). FIX-A (Cefixime) exhibits very good activity against most of the Enterobacteriaceae, Haemophilus influenzae and Neisseria gonorrhoeae (including -lactamase producing strains), -hemolytic streptococci of groups A and B and Streptococcus pneumoniae.Absorption is about 40% to 50% whether administered with or without food.COMPOSITIONCapsule: Each capsule contains Cefixime Trihydrate USP equivalent to Cefixime 200 mg.DS Capsule : Each capsule contains Cefixime Trihydrate USP equivalent to Cefixime 400 mg.Powder for suspension : Each 5 ml suspension contains CefiximeTrihydrate USP equivalent to Cefixime 100 mg after reconstitution.INDICATIONSFIX-A (Cefixime) is indicated for the treatment of the following acute infections caused by the susceptible microorganisms. 1) Upper respiratory tract infections e.g. otitis media and other URTI where the causative organism is known or suspected to be resistant to other commonly used antibiotics, or where treatment failure may carry significant risk. 2) Lower respiratory tract infections e.g. bronchitis. 3)Urinary tract infections e.g. cystitis, cystourethritis, uncomplicated pyelonephritis.4) Uncomplicated gonorrhea (cervical/ urethral).DOSAGE AND ADMINISTRATIONAdult and children over 12 years : The recommended adult dose is 200-400 mg (1 to 2 Capsules) daily, given either as a single dose or in two divided doses for 7-14 days depending on the severity of the infection.For the treatment of uncomplicated cervical/urethral gonococcal infections, a single oral dose of Cefixime 400 mg (Fix-A DS) is recommended. Single 800 mg may be given if essential.Children upto 12 years : Usually 8mg/kg/day given as a single dose or in two divided doses or for children of age :1/2 - 1 Year : 3.75 ml or 75 mg1 - 4 Years : 5 ml or 100 mg5 - 10 Years : 10 ml or 200 mg11-12 Years : 15 ml or 300 mg above 12 Years : adult dose should be given.OR AS DIRECTED BY THE PHYSICIAN.SIDE EFFECTSThe drug is generally well tolerated. The most frequent side effects observed are diarrhea and stool changes; that has been more commonly associated with higher doses. The drug should be discontinued if marked diarrhea occur. Other side effects seen less frequently are nausea, abdominal pain, dyspepsia, vomiting, flatulence, headache and dizziness. Allergies in the form of rash, pruritus, urticaria, drug fever and arthralgia have been reported. These reactions usually subsided upon discontinuation of therapy.PRECAUTIONSThe drug should be prescribed with caution in individuals with a history of gastrointestinal disease, particularly colitis. The drug should be given with caution in patients with marked impaired renal function as well as those undergoing continuous ambulatory peritoneal dialysis and hemodialysis. Dosage adjustment is only necessary in severe renal failure (creatinine clearance <20 ml. min-1 ), in that case a dose of 200 mg once daily should not be exceeded.Use in pregnancy and lactationThere are no adequate and well controlled studies in pregnant women. FIX-A (Cefixime) should therefore not be used in pregnancy or in nursing mothers unless considered essential by the physician.CONTRAINDICATIONSHypersensitivity to cephalosporin antibiotics.SUPPLYFIX-A Capsule : Each box contains 34 capsules in Alu-Alu blister strips.FIX-A DS Capsule : Each box contains 24 capsules in Alu-Alu blister strips.FIX-A powder for suspension 37.5 ml: Each bottle contains dry powder for the preparation of 37.5 ml suspension. A 5 ml spoon and a 10 ml measuring cup is given.FIX-A powder for suspension 50 ml: Each bottle contains dry powderfor the preparation of 50 ml suspension. A 5 ml spoon and a 10 ml measuring cup is given.FIX-A powder for suspension 75 ml: Each bottle contains dry powder for the preparation of 75 ml suspension. A 5 ml spoon and a 10 ml measuring cup is given...
Tk.130.00/=
Fix-A DS 400 mg Capsule
Fix-A DS 400 mg CapsuleDESCRIPTIONFIX-A (Cefixime) is a third generation semisynthetic cephalosporin antibiotic for oral administration. FIX-A (Cefixime) is bactericidal against a broad spectrum of gram positive and gram-negative bacteria at easily achievable plasma concentrations. FIX-A (Cefixime) is also highly stable in the presence of beta-lactamase enzyme. As a result, many organism resistant to penicillins and some cephalosporins due to the presence of beta-lactamases, may be susceptible to FIX-A (Cefixime). FIX-A (Cefixime) exhibits very good activity against most of the Enterobacteriaceae, Haemophilus influenzae and Neisseria gonorrhoeae (including -lactamase producing strains), -hemolytic streptococci of groups A and B and Streptococcus pneumoniae.Absorption is about 40% to 50% whether administered with or without food.COMPOSITIONCapsule: Each capsule contains Cefixime Trihydrate USP equivalent to Cefixime 200 mg.DS Capsule : Each capsule contains Cefixime Trihydrate USP equivalent to Cefixime 400 mg.Powder for suspension : Each 5 ml suspension contains CefiximeTrihydrate USP equivalent to Cefixime 100 mg after reconstitution.INDICATIONSFIX-A (Cefixime) is indicated for the treatment of the following acute infections caused by the susceptible microorganisms. 1) Upper respiratory tract infections e.g. otitis media and other URTI where the causative organism is known or suspected to be resistant to other commonly used antibiotics, or where treatment failure may carry significant risk. 2) Lower respiratory tract infections e.g. bronchitis. 3)Urinary tract infections e.g. cystitis, cystourethritis, uncomplicated pyelonephritis.4) Uncomplicated gonorrhea (cervical/ urethral).DOSAGE AND ADMINISTRATIONAdult and children over 12 years : The recommended adult dose is 200-400 mg (1 to 2 Capsules) daily, given either as a single dose or in two divided doses for 7-14 days depending on the severity of the infection.For the treatment of uncomplicated cervical/urethral gonococcal infections, a single oral dose of Cefixime 400 mg (Fix-A DS) is recommended. Single 800 mg may be given if essential.Children upto 12 years : Usually 8mg/kg/day given as a single dose or in two divided doses or for children of age :1/2 - 1 Year : 3.75 ml or 75 mg1 - 4 Years : 5 ml or 100 mg5 - 10 Years : 10 ml or 200 mg11-12 Years : 15 ml or 300 mg above 12 Years : adult dose should be given.OR AS DIRECTED BY THE PHYSICIAN.SIDE EFFECTSThe drug is generally well tolerated. The most frequent side effects observed are diarrhea and stool changes; that has been more commonly associated with higher doses. The drug should be discontinued if marked diarrhea occur. Other side effects seen less frequently are nausea, abdominal pain, dyspepsia, vomiting, flatulence, headache and dizziness. Allergies in the form of rash, pruritus, urticaria, drug fever and arthralgia have been reported. These reactions usually subsided upon discontinuation of therapy.PRECAUTIONSThe drug should be prescribed with caution in individuals with a history of gastrointestinal disease, particularly colitis. The drug should be given with caution in patients with marked impaired renal function as well as those undergoing continuous ambulatory peritoneal dialysis and hemodialysis. Dosage adjustment is only necessary in severe renal failure (creatinine clearance <20 ml. min-1 ), in that case a dose of 200 mg once daily should not be exceeded.Use in pregnancy and lactationThere are no adequate and well controlled studies in pregnant women. FIX-A (Cefixime) should therefore not be used in pregnancy or in nursing mothers unless considered essential by the physician.CONTRAINDICATIONSHypersensitivity to cephalosporin antibiotics.SUPPLYFIX-A Capsule : Each box contains 34 capsules in Alu-Alu blister strips.FIX-A DS Capsule : Each box contains 24 capsules in Alu-Alu blister strips.FIX-A powder for suspension 37.5 ml: Each bottle contains dry powder for the preparation of 37.5 ml suspension. A 5 ml spoon and a 10 ml measuring cup is given.FIX-A powder for suspension 50 ml: Each bottle contains dry powderfor the preparation of 50 ml suspension. A 5 ml spoon and a 10 ml measuring cup is given.FIX-A powder for suspension 75 ml: Each bottle contains dry powder for the preparation of 75 ml suspension. A 5 ml spoon and a 10 ml measuring cup is given...
Tk.50.35/=
Fix-A DS 50 ml Suspension
Fix-A DSDESCRIPTIONFIX-A (Cefixime) is a third generation semisynthetic cephalosporin antibiotic for oral administration. FIX-A (Cefixime) is bactericidal against a broad spectrum of gram positive and gram-negative bacteria at easily achievable plasma concentrations. FIX-A (Cefixime) is also highly stable in the presence of beta-lactamase enzyme. As a result, many organism resistant to penicillins and some cephalosporins due to the presence of beta-lactamases, may be susceptible to FIX-A (Cefixime). FIX-A (Cefixime) exhibits very good activity against most of the Enterobacteriaceae, Haemophilus influenzae and Neisseria gonorrhoeae (including -lactamase producing strains), -hemolytic streptococci of groups A and B and Streptococcus pneumoniae.Absorption is about 40% to 50% whether administered with or without food.COMPOSITIONCapsule: Each capsule contains Cefixime Trihydrate USP equivalent to Cefixime 200 mg.DS Capsule : Each capsule contains Cefixime Trihydrate USP equivalent to Cefixime 400 mg.Powder for suspension : Each 5 ml suspension contains CefiximeTrihydrate USP equivalent to Cefixime 100 mg after reconstitution.INDICATIONSFIX-A (Cefixime) is indicated for the treatment of the following acute infections caused by the susceptible microorganisms. 1) Upper respiratory tract infections e.g. otitis media and other URTI where the causative organism is known or suspected to be resistant to other commonly used antibiotics, or where treatment failure may carry significant risk. 2) Lower respiratory tract infections e.g. bronchitis. 3)Urinary tract infections e.g. cystitis, cystourethritis, uncomplicated pyelonephritis.4) Uncomplicated gonorrhea (cervical/ urethral).DOSAGE AND ADMINISTRATIONAdult and children over 12 years : The recommended adult dose is 200-400 mg (1 to 2 Capsules) daily, given either as a single dose or in two divided doses for 7-14 days depending on the severity of the infection.For the treatment of uncomplicated cervical/urethral gonococcal infections, a single oral dose of Cefixime 400 mg (Fix-A DS) is recommended. Single 800 mg may be given if essential.Children upto 12 years : Usually 8mg/kg/day given as a single dose or in two divided doses or for children of age :1/2 - 1 Year : 3.75 ml or 75 mg1 - 4 Years : 5 ml or 100 mg5 - 10 Years : 10 ml or 200 mg11-12 Years : 15 ml or 300 mg above 12 Years : adult dose should be given.OR AS DIRECTED BY THE PHYSICIAN.SIDE EFFECTSThe drug is generally well tolerated. The most frequent side effects observed are diarrhea and stool changes; that has been more commonly associated with higher doses. The drug should be discontinued if marked diarrhea occur. Other side effects seen less frequently are nausea, abdominal pain, dyspepsia, vomiting, flatulence, headache and dizziness. Allergies in the form of rash, pruritus, urticaria, drug fever and arthralgia have been reported. These reactions usually subsided upon discontinuation of therapy.PRECAUTIONSThe drug should be prescribed with caution in individuals with a history of gastrointestinal disease, particularly colitis. The drug should be given with caution in patients with marked impaired renal function as well as those undergoing continuous ambulatory peritoneal dialysis and hemodialysis. Dosage adjustment is only necessary in severe renal failure (creatinine clearance <20 ml. min-1 ), in that case a dose of 200 mg once daily should not be exceeded.Use in pregnancy and lactationThere are no adequate and well controlled studies in pregnant women. FIX-A (Cefixime) should therefore not be used in pregnancy or in nursing mothers unless considered essential by the physician.CONTRAINDICATIONSHypersensitivity to cephalosporin antibiotics.SUPPLYFIX-A Capsule : Each box contains 34 capsules in Alu-Alu blister strips.FIX-A DS Capsule : Each box contains 24 capsules in Alu-Alu blister strips.FIX-A powder for suspension 37.5 ml: Each bottle contains dry powder for the preparation of 37.5 ml suspension. A 5 ml spoon and a 10 ml measuring cup is given.FIX-A powder for suspension 50 ml: Each bottle contains dry powderfor the preparation of 50 ml suspension. A 5 ml spoon and a 10 ml measuring cup is given.FIX-A powder for suspension 75 ml: Each bottle contains dry powder for the preparation of 75 ml suspension. A 5 ml spoon and a 10 ml measuring cup is given...
Tk.280.84/=
Fixpro 200 Cap
Fixpro 200 CapDescription:Fixpro (Cefixime) is a third generation semisynthetic cephalosporin antibiotic for oral administration. It is bactericidal against a broad spectrum of gram positive and gram negative bacteria at easily achievable plasma concentrations. It is highly stable in the presence of Beta-lactamase enzyme. As a result, many organisms resistant to penicillins and some cephalsporins due to the presence of beta-lactamases, may be susceptible to Cefixime. Absorption of it is about 40% to 50% whether administered with or without food.IndicationFixpro (Cefixime) is indicated in the treatment of the following infections when caused by the susceptible strains of the designated microorganisms:Uncomplicated urinary tract infections caused by Escherichia coli and Proteus mirabilis. Otitis Media caused by Haemophilus influenzae, Moraxella catarrhalis and Streptococcus pyogenes. Pharyngitis and tonsillitis caused by Streptococcus pyogenes. Acute bronchitis and acute exacerbations of chronic bronchitis caused by Streptococcus pneumoniae and Haemophilus influenzae. Uncomplicated gonorrhoea (cervical/urethral) caused by Neisseria gonorrhoeae.Dosage & AdministrationAdult and children over 12 years: The recommended adult dose is 200-400 mg (1 to 2 capsules) daily, given either as a single dose or in two divided doses for 7-14 days depending on the severity of the infection. For the treatment of uncomplicated cervical/urethral gonococcal infections, a single oral dose of Cefixime 400 mg is recommended. Single 800 mg may be given if essential.Children upto 12 years: Usually 8mg/kg/day given as a single dose or in two divided doses or may be given as following :½-1 year : 3.75 ml or 75 mg daily.1-4 years : 5 ml or 100 mg daily.5-10 years : 10 ml or 200 mg daily.11-12 years : 15 ml or 300 mg daily.The safety and efficacy of Cefixime has not been established in children aged less than 6 months.The usual course of treatment is 7 days. This may be continued for up to 14 days as in typhoid or in any severe infection, if physicians desire. In typhoid fever, dosage should be 10mg/kg/day for 14 days.ContraindicationIt is contraindicated in hypersensitivity to Cefixime or other cephalosporins.PrecautionThe drug should be prescribed with caution in individuals with a history of gastrointestinal disease, particularly colitis. The drug should be given with caution in patients with marked impaired renal function as well as those undergoing continuous ambulatory peritoneal dialysis and hemodialysis. Dosage adjustment is only necessary in severe renal failure (creatinine clearance < 20 ml.min-1), in that case a dose of 200 mg once daily should not be exceeded.Side EffectsThe drug is generally well tolerated. The most frequent side effects are diarrhoea and stool changes; that have been more commonly associated with higher doses. Other side effects are nausea, abdominal pain, dyspepsia, vomiting, flatulence, headache and dizziness. Allergies in the form of rash, pruritus, urticaria, drug fever and arthralgia have been reported. These reactions usually subsided upon dicontinuation of therapy.Drug InteractionCarbamazepine: Concomitant use elevates the carbamazepine level. Warfarin and other anticoagulants: Concomitant use increases prothrombin time.Pregnancy & LactationUS FDA Pregnancy Category of Cefixime is B. There are, however, no adequate and well-controlled studies in pregnant women. Because animal reproduction studies are not always predictive of human response, this drug should be used during pregnancy only if clearly needed. It is not known that Cefixime is excreted in human milk. So, caution should be exercised when Cefixime is administered to a nursing woman.Storage ConditionKeep in a dry place away from light and heat. Keep out of the reach of children...
Tk.30.21/=
Fixpro 400 Cap
Fixpro 400 CapDescription:Fixpro (Cefixime) is a third generation semisynthetic cephalosporin antibiotic for oral administration. It is bactericidal against a broad spectrum of gram positive and gram negative bacteria at easily achievable plasma concentrations. It is highly stable in the presence of Beta-lactamase enzyme. As a result, many organisms resistant to penicillins and some cephalsporins due to the presence of beta-lactamases, may be susceptible to Cefixime. Absorption of it is about 40% to 50% whether administered with or without food.IndicationFixpro (Cefixime) is indicated in the treatment of the following infections when caused by the susceptible strains of the designated microorganisms:Uncomplicated urinary tract infections caused by Escherichia coli and Proteus mirabilis. Otitis Media caused by Haemophilus influenzae, Moraxella catarrhalis and Streptococcus pyogenes. Pharyngitis and tonsillitis caused by Streptococcus pyogenes. Acute bronchitis and acute exacerbations of chronic bronchitis caused by Streptococcus pneumoniae and Haemophilus influenzae. Uncomplicated gonorrhoea (cervical/urethral) caused by Neisseria gonorrhoeae.Dosage & AdministrationAdult and children over 12 years: The recommended adult dose is 200-400 mg (1 to 2 capsules) daily, given either as a single dose or in two divided doses for 7-14 days depending on the severity of the infection. For the treatment of uncomplicated cervical/urethral gonococcal infections, a single oral dose of Cefixime 400 mg is recommended. Single 800 mg may be given if essential.Children upto 12 years: Usually 8mg/kg/day given as a single dose or in two divided doses or may be given as following :½-1 year : 3.75 ml or 75 mg daily.1-4 years : 5 ml or 100 mg daily.5-10 years : 10 ml or 200 mg daily.11-12 years : 15 ml or 300 mg daily.The safety and efficacy of Cefixime has not been established in children aged less than 6 months.The usual course of treatment is 7 days. This may be continued for up to 14 days as in typhoid or in any severe infection, if physicians desire. In typhoid fever, dosage should be 10mg/kg/day for 14 days.ContraindicationIt is contraindicated in hypersensitivity to Cefixime or other cephalosporins.PrecautionThe drug should be prescribed with caution in individuals with a history of gastrointestinal disease, particularly colitis. The drug should be given with caution in patients with marked impaired renal function as well as those undergoing continuous ambulatory peritoneal dialysis and hemodialysis. Dosage adjustment is only necessary in severe renal failure (creatinine clearance < 20 ml.min-1), in that case a dose of 200 mg once daily should not be exceeded.Side EffectsThe drug is generally well tolerated. The most frequent side effects are diarrhoea and stool changes; that have been more commonly associated with higher doses. Other side effects are nausea, abdominal pain, dyspepsia, vomiting, flatulence, headache and dizziness. Allergies in the form of rash, pruritus, urticaria, drug fever and arthralgia have been reported. These reactions usually subsided upon dicontinuation of therapy.Drug InteractionCarbamazepine: Concomitant use elevates the carbamazepine level. Warfarin and other anticoagulants: Concomitant use increases prothrombin time.Pregnancy & LactationUS FDA Pregnancy Category of Cefixime is B. There are, however, no adequate and well-controlled studies in pregnant women. Because animal reproduction studies are not always predictive of human response, this drug should be used during pregnancy only if clearly needed. It is not known that Cefixime is excreted in human milk. So, caution should be exercised when Cefixime is administered to a nursing woman.Storage ConditionKeep in a dry place away from light and heat. Keep out of the reach of children...
Tk.50.34/=
Fixpro 50 ml Susp.
Fixpro 50 ml Susp.Description:Fixpro (Cefixime) is a third generation semisynthetic cephalosporin antibiotic for oral administration. It is bactericidal against a broad spectrum of gram positive and gram negative bacteria at easily achievable plasma concentrations. It is highly stable in the presence of Beta-lactamase enzyme. As a result, many organisms resistant to penicillins and some cephalsporins due to the presence of beta-lactamases, may be susceptible to Cefixime. Absorption of it is about 40% to 50% whether administered with or without food.IndicationFixpro (Cefixime) is indicated in the treatment of the following infections when caused by the susceptible strains of the designated microorganisms:Uncomplicated urinary tract infections caused by Escherichia coli and Proteus mirabilis. Otitis Media caused by Haemophilus influenzae, Moraxella catarrhalis and Streptococcus pyogenes. Pharyngitis and tonsillitis caused by Streptococcus pyogenes. Acute bronchitis and acute exacerbations of chronic bronchitis caused by Streptococcus pneumoniae and Haemophilus influenzae. Uncomplicated gonorrhoea (cervical/urethral) caused by Neisseria gonorrhoeae.Dosage & AdministrationAdult and children over 12 years: The recommended adult dose is 200-400 mg (1 to 2 capsules) daily, given either as a single dose or in two divided doses for 7-14 days depending on the severity of the infection. For the treatment of uncomplicated cervical/urethral gonococcal infections, a single oral dose of Cefixime 400 mg is recommended. Single 800 mg may be given if essential.Children upto 12 years: Usually 8mg/kg/day given as a single dose or in two divided doses or may be given as following :½-1 year : 3.75 ml or 75 mg daily.1-4 years : 5 ml or 100 mg daily.5-10 years : 10 ml or 200 mg daily.11-12 years : 15 ml or 300 mg daily.The safety and efficacy of Cefixime has not been established in children aged less than 6 months.The usual course of treatment is 7 days. This may be continued for up to 14 days as in typhoid or in any severe infection, if physicians desire. In typhoid fever, dosage should be 10mg/kg/day for 14 days.ContraindicationIt is contraindicated in hypersensitivity to Cefixime or other cephalosporins.PrecautionThe drug should be prescribed with caution in individuals with a history of gastrointestinal disease, particularly colitis. The drug should be given with caution in patients with marked impaired renal function as well as those undergoing continuous ambulatory peritoneal dialysis and hemodialysis. Dosage adjustment is only necessary in severe renal failure (creatinine clearance < 20 ml.min-1), in that case a dose of 200 mg once daily should not be exceeded.Side EffectsThe drug is generally well tolerated. The most frequent side effects are diarrhoea and stool changes; that have been more commonly associated with higher doses. Other side effects are nausea, abdominal pain, dyspepsia, vomiting, flatulence, headache and dizziness. Allergies in the form of rash, pruritus, urticaria, drug fever and arthralgia have been reported. These reactions usually subsided upon dicontinuation of therapy.Drug InteractionCarbamazepine: Concomitant use elevates the carbamazepine level. Warfarin and other anticoagulants: Concomitant use increases prothrombin time.Pregnancy & LactationUS FDA Pregnancy Category of Cefixime is B. There are, however, no adequate and well-controlled studies in pregnant women. Because animal reproduction studies are not always predictive of human response, this drug should be used during pregnancy only if clearly needed. It is not known that Cefixime is excreted in human milk. So, caution should be exercised when Cefixime is administered to a nursing woman.Storage ConditionKeep in a dry place away from light and heat. Keep out of the reach of children...
Tk.196.33/=
